Sign in

CIK 0001420720

  • Non-accelerated filer
  • Smaller reporting company
Ticker
IBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
262797813
Phone
+1 302-355-0650
Business address
600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
Former names
iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-02-20 ERWIN ROBERT L President Returned to the company · Stock Option (right to buy) −30,000 232,500
2019-02-20 ERWIN ROBERT L President Grant or award · Stock Option (right to buy) +22,500 232,500
2019-02-20 ERWIN ROBERT L President Returned to the company · Stock Option (right to buy) −60,000 232,500
2019-02-20 ERWIN ROBERT L President Grant or award · Stock Option (right to buy) +45,000 232,500
2019-02-20 ERWIN ROBERT L President Returned to the company · Stock Option (right to buy) −75,000 232,500
2019-02-20 ERWIN ROBERT L President Grant or award · Stock Option (right to buy) +56,250 232,500
2019-02-20 ERWIN ROBERT L President Returned to the company · Stock Option (right to buy) −30,000 232,500
2019-02-20 ERWIN ROBERT L President Grant or award · Stock Option (right to buy) +22,500 232,500
2019-02-20 Kay Robert Executive Chairman and CEO Returned to the company · Stock Option (right to buy) −25,000 410,000
2019-02-20 Kay Robert Executive Chairman and CEO Grant or award · Stock Option (right to buy) +18,750 410,000
2019-02-20 Kay Robert Executive Chairman and CEO Returned to the company · Stock Option (right to buy) −30,000 410,000
2019-02-20 Kay Robert Executive Chairman and CEO Grant or award · Stock Option (right to buy) +22,500 410,000
2019-02-20 Kay Robert Executive Chairman and CEO Returned to the company · Stock Option (right to buy) −50,000 410,000
2019-02-20 Kay Robert Executive Chairman and CEO Grant or award · Stock Option (right to buy) +37,500 410,000
2019-02-20 Kay Robert Executive Chairman and CEO Returned to the company · Stock Option (right to buy) −50,000 410,000
2019-02-20 Kay Robert Executive Chairman and CEO Grant or award · Stock Option (right to buy) +37,500 410,000
2019-02-20 Kay Robert Executive Chairman and CEO Returned to the company · Stock Option (right to buy) −30,000 410,000
2019-02-20 Kay Robert Executive Chairman and CEO Grant or award · Stock Option (right to buy) +22,500 410,000
2019-02-20 Kay Robert Executive Chairman and CEO Returned to the company · Stock Option (right to buy) −30,000 410,000
2019-02-20 Kay Robert Executive Chairman and CEO Grant or award · Stock Option (right to buy) +22,500 410,000

Page 10 of 22 · 423 trades